Skip to content
Carmelics
TopicsThinkersChangesContributorsLoading account…

    Carmelics

    A reasoning platform. Break down any belief into clear reasons, explore both sides, and weigh the evidence honestly.

    Navigate

    • Topics
    • Search
    • Recent Changes
    • Contribute
    • How It Works
    • Glossary
    • Thinkers
    • Contributors
    • About
    • Statistics
    • Terms
    • Privacy

    Database

    Statements
    —
    Perspectives
    —
    Topics
    —

    Press ? for keyboard shortcuts

    LoyalLoyalJusticeJustice
    Made withinDC&Austin
    Statements
    321,452
    Perspectives
    108,905
    Topics
    42
    Home/Original/inverse
    See Original
    Inverse View

    It is not the case that Therefore, producing better-than-normal damage resistance cannot be classified as treatment even when targeting a predictable pathological risk.

    ?Set your confidence on the premises below to see your aggregate.

    Reasons For

    1 perspective
    Reason for
    ?
    • 1.Predictable pathological risk means the condition is medically relevant; preventing foreseeable harm is quintessentially treatment.
      ?

      Think about whether this reason is strong or weak

    • 2.Labeling something 'enhancement' because it exceeds normal function ignores that preventing disease IS the medical goal.
      ?

      Think about whether this reason is strong or weak

    • 3.The distinction collapses when interventions address vulnerability to pathology—motivation and outcome matter more than degree.
      ?

      Think about whether this reason is strong or weak

    Reasons Against

    1 perspective
    Reason against
    ?
    • 1.Treatment addresses deficits below species-typical functioning; enhancement creates capabilities above the normal range.
      ?

      Think about whether this reason is strong or weak

    • 2.Preventive interventions targeting future disease risks differ categorically from corrective ones addressing present pathology.
      ?

      Think about whether this reason is strong or weak

    • 3.The treatment/enhancement distinction requires comparing outcomes to normal baselines, not to absent disease states.
      ?

      Think about whether this reason is strong or weak

    Next step

    Based on where you are in your exploration

    Strongest counterpoint
    Explore the most compelling reason on the other side.